PHARVARIS N V's ticker is PHVS and the CUSIP is N69605108. A total of 23 filers reported holding PHARVARIS N V in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,211,000 | -68.6% | 399,875 | -13.6% | 0.01% | -64.3% |
Q2 2022 | $10,224,000 | +1.7% | 462,630 | -14.0% | 0.01% | +27.3% |
Q1 2022 | $10,054,000 | +17.5% | 537,630 | -0.6% | 0.01% | +22.2% |
Q4 2021 | $8,556,000 | -11.0% | 540,811 | -2.9% | 0.01% | -18.2% |
Q3 2021 | $9,609,000 | – | 557,059 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 3,743,450 | $78,125,802 | 43.39% |
venBio Partners LLC | 4,264,672 | $89,003,705 | 25.24% |
Bain Capital Life Sciences Investors, LLC | 4,784,674 | $99,856,146 | 11.17% |
5AM Venture Management, LLC | 587,600 | $12,263,212 | 3.53% |
VR Adviser, LLC | 1,563,513 | $32,630,516 | 3.44% |
Novo Holdings A/S | 1,329,325 | $27,743,013 | 2.05% |
Cormorant Asset Management, LP | 1,361,460 | $28,413,670 | 1.66% |
GENERAL ATLANTIC, L.P. | 4,406,252 | $91,958,479 | 1.42% |
Foresite Capital Management V, LLC | 33,142 | $691,674 | 1.10% |
Soleus Capital Management, L.P. | 343,975 | $7,178,758 | 0.66% |